Cargando…

Analysis of blood coagulation in mice: pre-analytical conditions and evaluation of a home-made assay for thrombin-antithrombin complexes

BACKGROUND: The use of mouse models for the study of thrombotic disorders has gained increasing importance. Methods for measurement of coagulation activation in mice are, however, scarce. The primary aim of this study was to develop a specific mouse thrombin-antithrombin (TAT) ELISA for measurement...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sommeijer, Dirkje W, van Oerle, René, Reitsma, Pieter H, Timmerman, Janneke J, Meijers, Joost CM, Spronk, Henri MH, ten Cate, Hugo
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Original Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1215525/ https://www.ncbi.nlm.nih.gov/pubmed/16115315 http://dx.doi.org/10.1186/1477-9560-3-12

Ejemplares similares

Thrombin Generation Capacity of Prothrombin Complex Concentrate in an In Vitro Dilutional Model
por: Grottke, Oliver, et al.
Publicado: (2013)

A new method to determine tissue specific tissue factor thrombomodulin activities: endotoxin and particulate air pollution induced disbalance
por: Frederix, Kim, et al.
Publicado: (2008)

Thrombin Generation in the Glasgow Myocardial Infarction Study
por: Smid, Machiel, et al.
Publicado: (2013)

Blood coagulation and the risk of atherothrombosis: a complex relationship
por: Spronk, Henri MH, et al.
Publicado: (2004)

Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background
por: van Paridon, Pauline C. S., et al.
Publicado: (2022)

Factor XIa and Thrombin Generation Are Elevated in Patients with Acute Coronary Syndrome and Predict Recurrent Cardiovascular Events
por: Loeffen, Rinske, et al.
Publicado: (2016)

Calibrated automated thrombogram II: removing barriers for thrombin generation measurements
por: Giesen, P. L. A., et al.
Publicado: (2021)

Thrombin generation by calibrated automated thrombography in goat plasma: Optimization of an assay
por: D'Alessandro, Elisa, et al.
Publicado: (2021)

Thrombin Generation and Atherothrombosis: What Does the Evidence Indicate?
por: ten Cate, Hugo, et al.
Publicado: (2016)

Suggestions for global coagulation assays for the assessment of COVID-19 associated hypercoagulability
por: van de Berg, Tom W., et al.
Publicado: (2021)

Thrombin generation capacity is enhanced by low antithrombin activity and depends on the activity of the related coagulation factors
por: Tsuchida, Takumi, et al.
Publicado: (2022)

Early Changes in the Antithrombin and Thrombin-Antithrombin Complex in Patients With Paroxysmal Atrial Fibrillation
por: Negreva, Mariya, et al.
Publicado: (2016)

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
por: Henskens, Yvonne M. C., et al.
Publicado: (2018)

Thrombin generation in cardiovascular disease and mortality – results from the Gutenberg Health Study
por: van Paridon, Pauline C.S., et al.
Publicado: (2019)

Validation of a modified thromboelastometry approach to detect changes in fibrinolytic activity
por: Kuiper, Gerhardus J. A. J. M., et al.
Publicado: (2016)

Thrombin–Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis
por: Hulshof, Anne-Marije, et al.
Publicado: (2021)

Thrombin-antithrombin complex measurement using a point-of-care testing device for diagnosis of disseminated intravascular coagulation in dogs
por: Rimpo, Kenji, et al.
Publicado: (2018)

Effects of the PAR-1 Antagonist Vorapaxar on Platelet Activation and Coagulation Biomarkers in Patients with Stable Coronary Artery Disease
por: Olie, Renske H., et al.
Publicado: (2019)

Evaluation of the analytical performance of the PC100 platelet counter
por: Nagy, Magdolna, et al.
Publicado: (2021)

Functional Characterization of Antithrombin Mutations by Monitoring of Thrombin Inhibition Kinetics
por: Reda, Sara, et al.
Publicado: (2021)

Thrombin formation via the intrinsic coagulation pathway and von Willebrand factor reflect disease severity in COVID-19
por: Busch, Matthias H., et al.
Publicado: (2022)

Thrombin antithrombin complex and IL-18 serum levels in stroke patients
por: Piazza, Ornella, et al.
Publicado: (2010)

Increased Clot Formation in the Absence of Increased Thrombin Generation in Patients with Peripheral Arterial Disease: A Case–Control Study
por: Kleinegris, Marie-Claire F., et al.
Publicado: (2017)

Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice
por: Posthuma, Jelle J., et al.
Publicado: (2019)

Characterization of Thrombin Generation Curve Shape in Presence of Platelets from Acute Venous Thromboembolism Patients
por: Lagrange, Jeremy, et al.
Publicado: (2020)

Is antithrombin treatment of disseminated intravascular coagulation a quixotic goal?
por: Seam, Nitin, et al.
Publicado: (2014)

Influence of high‐dose antithrombin on platelet function and blood coagulation
por: Miike, Toru, et al.
Publicado: (2021)

Antithrombin III/SerpinC1 insufficiency exacerbates renal ischemia/reperfusion injury
por: Wang, Feng, et al.
Publicado: (2015)

Elevated Microparticles, Thrombin-antithrombin and VEGF Levels in Colorectal Cancer Patients Undergoing Chemotherapy
por: Wojtukiewicz, Marek Z., et al.
Publicado: (2020)

Tailoring the effect of antithrombin-targeting therapy in haemophilia A using in silico thrombin generation
por: de Laat-Kremers, Romy M. W., et al.
Publicado: (2021)

Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation
por: Akahoshi, Tomohiko, et al.
Publicado: (2022)

Effects of Fibrinogen Concentrate on Thrombin Generation, Thromboelastometry Parameters, and Laboratory Coagulation Testing in a 24-Hour Porcine Trauma Model
por: Zentai, Christian, et al.
Publicado: (2015)

Antithrombin III (AT) and recombinant tissue plasminogen activator (R-TPA) used singly and in combination versus supportive care for treatment of endotoxin-induced disseminated intravascular coagulation (DIC) in the neonatal pig
por: Davis-Jackson, Rachel, et al.
Publicado: (2006)

Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction
por: Slofstra, Sjoukje H, et al.
Publicado: (2006)

Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017)

Association of antithrombin with development of trauma-induced disseminated intravascular coagulation and outcomes
por: Wada, Takeshi, et al.
Publicado: (2022)

Effect of plasma thrombin-antithrombin complex on ischemic stroke: a systematic review and meta-analysis
por: Song, Peipei, et al.
Publicado: (2023)

Thrombin Decrease in Thrombin Generation after Heparin Administration in a Homozygous Type II Heparin-Binding Site Antithrombin-Deficient Pregnant Woman
por: Malíková, Ivana, et al.
Publicado: (2023)

ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin‐6
por: Willems, Loes H., et al.
Publicado: (2021)

Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure
por: Kuroda, Hiromitsu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vkahmd530mprsfhf3khdjfi9ur